Key Metrics of Moderna
Revenue$6.8B▼ 64.4% YoYFY 2023
Operating income−$4.2B▼ 145.0% YoY
Net profit−$4.7B▼ 156.4% YoY
Shareholders' equity$13.9B
Market cap$80.9BMRNA · $202.63
Competitors10identified
About Moderna
Sectors
Company details
- Website
- modernatx.com
- Founded
- 2018
- Registered office
- G.c. College Road, Cachar, Assam, Silchar, 788004
- Listed
- Nasdaq: MRNA (since 2018)
Operational Areas of Moderna
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Entity details
CINU27310AS2021PTC022288
LEI code6488P446NI4NK990JF83
State codeAS
PIN code788004
Current legal nameMODERNA
Classification—
Listing statusUnlisted
Registration no.022288
Company age—
PAN—
CountryUnited States
CitySilchar
StateAssam
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—
Compliance
Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026
Industry classification
NIC code27310
Description of main activityManufacture of basic metals (iron, steel, non-ferrous, casting)
Description of business activityManufacture of basic metals (iron, steel, non-ferrous, casting)
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
US market & SEC filings
MRNA · Nasdaq · SEC CIK 0001682852
Last price · 23 Oct 2026
$202.63
−17.57%
Market cap$80.9B
P/E—On FY 2023 diluted EPS
Volume49,947,303
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOUnited StatesListed 2018
MRNA share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingFiling compliance
AGM for FY 2025-2630 Sep 2026
Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026
Statutory due date · 6 days left
MGT-7 for FY 2025-2629 Nov 2026
Statutory due date · 36 days left
Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeG.C. COLLEGE ROAD, Cachar, Assam, SILCHAR, 788004
GSTIN—
Email—
Websitehttps://www.modernatx.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Moderna
Competitors10identified
Locations1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States | |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bio-rad.com | 1980 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | 10xgenomics.com | 2019 | United States |
Similar companies
C
Concord Biotech LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
E
ExelixisPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
BioMarin PharmaceuticalPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Bio-Rad LaboratoriesPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
T
Twist BiosciencePharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
R
Revvity Inc.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Becton DickinsonPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
C
CannamedicalPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
pharmaceutical industry, biotechnology industry
Filings
No filings on record yet.